FDA-Inspected Site

Boston Scientific Corporation

3 FDA inspections are on record for Boston Scientific Corporation in Lowell, United States.

483· Form 483 issued

Lowell, United States · Last updated July 10, 2026

Overview

  • 3 FDA inspections are on record.
  • 2 inspections produced a Form 483.
  • The most recent recorded inspection date is 2014-10-09.

At a glance

Inspections

3

Form 483s

2

EIRs

1

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
25 Sep 2014 – 9 Oct 2014Medical Devices & Rad Health483View 483 →
18 Mar 2011Not recorded483View 483 →
21 Aug 2009Not recordedClean

Observations on record

Form 483 observations cited at this site, most recent first.

9 Oct 2014
21 CFR 820.30(f)

Design verification - output does not meet input requirement

Cited by Tamara S Rosbury

9 Oct 2014
21 CFR 820.30(i)

Design changes - Lack of or Inadequate Procedures

Cited by Tamara S Rosbury

9 Oct 2014
21 CFR 820.100(a)

Lack of or inadequate procedures

Cited by Tamara S Rosbury

18 Mar 2011
21 CFR 820.30(b)

Design plans- updated

Cited by Stephen C Smith

18 Mar 2011
21 CFR 820.30(g)

Design validation - software validation documentation

Cited by Stephen C Smith

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 820.30(i)Cited across public-safe Form 483 observations2x
21 CFR 820.100(a)Cited across public-safe Form 483 observations1x
21 CFR 820.30(b)Cited across public-safe Form 483 observations1x
21 CFR 820.30(f)Cited across public-safe Form 483 observations1x
21 CFR 820.30(g)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Boston Scientific Corporation's 2 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat